We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF

6 hedge funds and large institutions have $854K invested in ARK Genomic Revolution ETF in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 36 (+3)

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

42% more capital invested

Capital invested by funds: $603K → $854K (+$251K)

4.88% more ownership

Funds ownership: 7.11%11.99% (+4.9%)

Holders
6
Holders Change
+3
Holders Change %
+100%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Jane Street
1
Jane Street
New York
$705K +$232K +13,555 +51%
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$60K +$58.4K +3,410 New
LTFS
3
Ladenburg Thalmann Financial Services
Florida
$51K +$49.6K +2,900 New
UBS Group
4
UBS Group
Switzerland
$16K -$13.5K -786 -46%
HFM
5
Hartford Financial Management
Connecticut
$16K +$8.34K +487 +107%
IA
6
IFP Advisors
Florida
$6K +$3.39K +198 New

ARKG Hedge Fund Activity: Q1 2016 in Review

6 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q1 2016, worth a combined $854K — up 42% from $603K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ARKG positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Jane Street, adding an estimated $232K. The largest seller was UBS Group, cutting an estimated $13.5K.

  • 6 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q1 2016, up from 3 in Q4 2015.
  • Funds reported $854K of ARK Genomic Revolution ETF stock for Q1 2016, up 42% quarter-over-quarter.
  • 3 funds opened new ARK Genomic Revolution ETF positions in Q1 2016 and 0 closed out, a net change of +3 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q1 2016 was Jane Street, an estimated $232K added.
  • The largest ARK Genomic Revolution ETF seller in Q1 2016 was UBS Group, an estimated $13.5K sold.

Based on aggregated 13F filings for Q1 2016.